Multimodal therapy for hepatocellular carcinoma: A complementary approach to liver transplantation

Annals of Hepatology

Volumn 9, Issue 1, 2010, Pages 23-32

  Schumacher, P Andrew ^a   Powell, James J ^a   MacNeill, Andrea J ^a   Buczkowski, Andrzej K ^b   Erb, Siegfried R ^c   Ho, Stephen G ^d   Scudamore, Charles H ^b   Steinbrecher, Urs P ^e   Weiss, Alan ^f   Yoshida, Eric ^f   Chung, Stephen W ^b  

^a Departments of Surgery   (Canada)

^b Departments of Medicine   (Canada)

^c Departments of Neurology   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e British Columbia Transplant   (Canada)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Chemoembolization; Liver resection; Liver transplantation; Radiofrequency ablation

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DOXORUBICIN; INTERFERON; LAMIVUDINE; RIBAVIRIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OBSERVATION; OVERALL SURVIVAL; PORTAL VEIN; PORTAL VEIN THROMBOSIS; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; VASCULAR PATENCY; ALTERNATIVE MEDICINE; CATHETER ABLATION; DRUG THERAPY; INJECTION; LIVER TUMOR; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DRUG THERAPY; ETHANOL; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77954614280     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31675-8     Document Type: Article

References (26)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 271-285.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
3. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 466-486.
4. Sangiovanni A, del Ninno E, Fasani P et al. Increased survival of cirrhotic patients with hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
6. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely affect survival. Hepatology 2001; 33: 1394-1403.
7. Roayaie S, Frischer J, Emre SH et al. Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 cm. Ann Surg 2002; 235: 533-539.
8. Toso C, Trotter J, Wei A, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008; 14: 1107-1115.
9. Yao FY, Bass NM, Nilolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention to treat principle and drop out from the waiting list. Liver Transpl 2002; 8: 873-883.
10. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
11. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 1999; 229: 790-799.
12. Poon RT, Fan ST, Lo CM, et al. Long term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage liver transplantation. Ann Surg 2002; 235: 373-382.
13. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-235.
14. Bruix J, Hessheimer AJ, Forner A, et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Onco-gene 2006; 25: 3848-3856.
15. Bruix J, Sherman M. Management of hepatocellular carcinoma; AASLD practice guideline. Hepatology 2005; 42: 1208-1236.
16. Rowe AJ, Meneghetti AT, Schumacher PA, et al. Periopera-tive analysis of laparoscopic versus open liver resection. Surgical Endoscopy 2009; 23: 1198-1203.
17. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
18. Fisher RA, Maluf D, Cotterell AH, Stravitz T, Wolfe L, Luketic V, et al. Non-resective ablation therapy for hepa-tocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004; 18: 502-512.
19. Fisher RA, Maluf DG, Wolf L, Williams B, Cotterall AH, Stra-vitz RT, Heuman D, Posner MP. Is hepatic transplant justified for primary liver cancer? J Surg Onc 2007; 95: 674-679.
20. Bismuth H, Chiche L, Adam R, et al. Liver resection versus liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 1993; 218: 145-51.
21. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-322.
22. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
23. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-461.
24. Okita K, Sakaida I, Hino K. Current strategies for chemo-prevention of hepatocellular carcinoma. Oncology 2002; 62(Suppl. 1): 24-28.
25. Lok AS. Prevention of hepatitis B virus-related hepatoce-llular carcinoma. Gastroenterology 2004; 127(Suppl. 1): S303-s309
26. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.